{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:29:10Z","timestamp":1791725350546,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005031","name":"Bhabha Atomic Research Centre","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005031","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol Phys Technol"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This study evaluates and compares the dosimetric performance of the Bhabha Atomic Research Centre (BARC)\n                    <jats:sup>106<\/jats:sup>\n                    Ru\/\n                    <jats:sup>106<\/jats:sup>\n                    Rh eye plaques and a commercially available similar BEBIG CCA eye plaque using Monte Carlo simulations via the FLUKA code. Simulations were performed in both spherical water and mathematical eye phantoms to determine dosimetric parameters such as reference absorbed dose rates, percentage depth doses, off-axis dose profiles, and 2D dose mappings. The on-axis reference absorbed dose rates at 1\u00a0mm depth in the mathematical eye phantom was calculated as 10.712\u2009\u00b1\u20090.003 mGy\/min-MBq for the BEBIG CCA plaque and 10.194\u2009\u00b1\u20090.003 mGy\/min-MBq for the BARC plaque, showing close agreement between the two applicators. Off-axis and depth dose distributions confirmed that the BARC plaque delivers comparable dose profiles to the BEBIG plaque, with all critical eye structure doses, including the lens, retina, and cornea, well within established tolerance limits. The similarity in dose distributions between water and mathematical phantoms suggests that water can serve as a practical approximation for dosimetry evaluations. This study demonstrates that the BARC plaque provides dosimetric characteristics comparable to the BEBIG plaque, support its potential use in clinical ophthalmic brachytherapy.\n                  <\/jats:p>","DOI":"10.1007\/s12194-025-00986-z","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:06:02Z","timestamp":1763442362000},"page":"125-135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Monte Carlo-based dosimetric comparison of indigenous and commercial 106Ru\/106Rh eye plaques using a mathematical eye phantom"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6918-849X","authenticated-orcid":false,"given":"Vandana","family":"Shrivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arghya","family":"Chattaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Palani","family":"Selvam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Pathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. K.","family":"Sapra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"5","key":"986_CR1","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1001\/archopht.1986.01050170045019","volume":"104","author":"JJ Augsburger","year":"1986","unstructured":"Augsburger JJ, et al. Enucleation vs cobalt plaque radiotherapy for malignant melanomas of the choroid and ciliary body. Arch Ophthalmol. 1986;104(5):655\u201361.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"986_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0167-8140(98)00095-4","volume":"49","author":"A S\u00e1nchez-Reyes","year":"1998","unstructured":"S\u00e1nchez-Reyes A, et al. Monte Carlo calculation of the dose distributions of two 106Ru eye applicators. Radiother Oncol. 1998;49(2):191\u20136.","journal-title":"Radiother Oncol"},{"key":"986_CR3","unstructured":"3. Cross, W.G., et al., Dosimetry of beta rays and low-energy photons for brachytherapy with sealed sources, ICRU Report 72. 2004."},{"issue":"4","key":"986_CR4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.brachy.2024.04.003","volume":"23","author":"R Kumar","year":"2024","unstructured":"Kumar R, et al. Dosimetry of indigenously developed 106Ru-106Rh ophthalmic plaque. Brachytherapy. 2024;23(4):443\u201356.","journal-title":"Brachytherapy"},{"key":"986_CR5","unstructured":"5. Group, C.O.M.S., The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. 2006."},{"issue":"3","key":"986_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/01.ieb.0000169321.64806.04","volume":"6","author":"CL Shields","year":"2005","unstructured":"Shields CL. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report no. 24. Evid Based Ophthalmol. 2005;6(3):158\u201360.","journal-title":"Evid Based Ophthalmol"},{"issue":"4","key":"986_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.5114\/jcb.2020.98108","volume":"12","author":"J Messer","year":"2020","unstructured":"Messer J, et al. Eye plaque brachytherapy versus enucleation for ocular melanoma: an analysis from the National Cancer Database. J Contemp Brachytherapy. 2020;12(4):303\u201310.","journal-title":"J Contemp Brachytherapy"},{"key":"986_CR8","doi-asserted-by":"crossref","unstructured":"8. Chiu-Tsao, S.T., et al., Dosimetry of 125I and 103Pd COMS eye plaques for intraocular tumors: Report of Task Group 129 by the AAPM and ABS. Medical physics, 2012. 39(10): p. 6161\u20136184.","DOI":"10.1118\/1.4749933"},{"issue":"2","key":"986_CR9","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/S0360-3016(03)00006-3","volume":"56","author":"S Nag","year":"2003","unstructured":"Nag S, et al. The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas. Int J Radiat Oncol Biol Phys. 2003;56(2):544\u201355.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"986_CR10","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1002\/mp.13996","volume":"47","author":"RM Thomson","year":"2020","unstructured":"Thomson RM, et al. AAPM recommendations on medical physics practices for ocular plaque brachytherapy: report of task group 221. Med Phys. 2020;47(5):e92\u2013124.","journal-title":"Med Phys"},{"key":"986_CR11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.radphyschem.2012.12.025","volume":"95","author":"N Barbosa","year":"2014","unstructured":"Barbosa N, et al. Brachytherapy treatment simulation of strontium-90 and ruthenium-106 plaques on small size posterior uveal melanoma using MCNPX code. Radiat Phys Chem. 2014;95:224\u20136.","journal-title":"Radiat Phys Chem"},{"issue":"3","key":"986_CR12","doi-asserted-by":"publisher","DOI":"10.14319\/ijcto.0203.8","volume":"2","author":"NA Barbosa","year":"2014","unstructured":"Barbosa NA, Da R, La R. Assessment of ocular beta radiation dose distribution due to 106Ru\/106Rh brachytherapy applicators using MCNPX Monte Carlo code. Int J Cancer Ther Oncol. 2014;2(3):02038.","journal-title":"Int J Cancer Ther Oncol"},{"issue":"7","key":"986_CR13","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1118\/1.1376441","volume":"28","author":"CG Soares","year":"2001","unstructured":"Soares CG, et al. Dosimetry of beta-ray ophthalmic applicators: comparison of different measurement methods. Med Phys. 2001;28(7):1373\u201384.","journal-title":"Med Phys"},{"issue":"10","key":"986_CR14","doi-asserted-by":"publisher","DOI":"10.1118\/1.4820368","volume":"40","author":"M Hermida-L\u00f3pez","year":"2013","unstructured":"Hermida-L\u00f3pez M. Calculation of dose distributions for 12 106Ru\/106Rh ophthalmic applicator models with the PENELOPE Monte Carlo code. Med Phys. 2013;40(10):101705.","journal-title":"Med Phys"},{"issue":"6","key":"986_CR15","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1002\/mp.12248","volume":"44","author":"M Hermida\u2013L\u00f3pez","year":"2017","unstructured":"Hermida\u2013L\u00f3pez M, Brualla L. Monte Carlo study of 106Ru\/106Rh ophthalmic plaques including the 106Rh gamma spectrum. Med Phys. 2017;44(6):2581\u20135.","journal-title":"Med Phys"},{"issue":"8","key":"986_CR16","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.ejmp.2016.07.636","volume":"32","author":"L Mostafa","year":"2016","unstructured":"Mostafa L, Rachid K, Ahmed SM. Comparison between beta radiation dose distribution due to LDR and HDR ocular brachytherapy applicators using GATE Monte Carlo platform. Phys Med. 2016;32(8):1007\u201318.","journal-title":"Phys Med"},{"key":"986_CR17","unstructured":"17. Moulavi, A. and M. Yazdani, Monte Carlo simulation of two 106Ru eye plaques in a new mathematical human eye model. 2008."},{"key":"986_CR18","doi-asserted-by":"crossref","unstructured":"18. Ballarini, F., et al. The FLUKA code: an overview. in Journal of Physics: Conference Series. 2006. IOP Publishing.","DOI":"10.1088\/1742-6596\/41\/1\/014"},{"key":"986_CR19","doi-asserted-by":"crossref","unstructured":"19. Battistoni, G., et al. The FLUKA code: Description and benchmarking. in AIP Conference proceedings. 2007. American Institute of Physics.","DOI":"10.1063\/1.2720455"},{"issue":"4","key":"986_CR20","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1002\/mp.12777","volume":"45","author":"M Hermida-L\u00f3pez","year":"2018","unstructured":"Hermida-L\u00f3pez M, Brualla L. Absorbed dose distributions from ophthalmic 106Ru\/106Rh plaques measured in water with radiochromic film. Med Phys. 2018;45(4):1699\u2013707.","journal-title":"Med Phys"},{"issue":"3","key":"986_CR21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.icrp.2008.10.001","volume":"38","author":"K Eckerman","year":"2008","unstructured":"Eckerman K, Endo A. Nuclear decay data for dosimetric calculations. ICRP publication 107. Ann ICRP. 2008;38(3):7\u201396.","journal-title":"Ann ICRP"},{"key":"986_CR22","unstructured":"22. EZB, G., User manual Ru-106 eye applicators TD04_002 \/ Rev. 11\/09. 2013."},{"key":"986_CR23","doi-asserted-by":"crossref","unstructured":"23. Valentin, J., Basic anatomical and physiological data for use in radiological protection: reference values: ICRP Publication 89. Annals of the ICRP, 2002. 32(3\u20134): p. 1-277.","DOI":"10.1016\/S0146-6453(03)00002-2"},{"issue":"2","key":"986_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0048-9697(76)90016-4","volume":"6","author":"E Hamilton","year":"1976","unstructured":"Hamilton E. Report of the task group on reference man, international commission on radiological protection publication 23. Sci Total Environ. 1976;6(2):201\u20132.","journal-title":"Sci Total Environ"},{"key":"986_CR25","unstructured":"25. Scott, J.A., Photon, electron, proton and neutron interaction data for body tissues: ICRU report 46. International commission on radiation units and measurements, Bethesda, 1992, $40.00. 1993, Society of Nuclear Medicine."},{"issue":"10","key":"986_CR26","doi-asserted-by":"publisher","first-page":"7021","DOI":"10.3390\/curroncol29100552","volume":"29","author":"S Bisello","year":"2022","unstructured":"Bisello S, et al. Dose\u2013volume constraints fOr oRganS At risk In Radiotherapy (CORSAIR): an \u201cAll-in-One\u201d multicenter\u2013multidisciplinary practical summary. Curr Oncol. 2022;29(10):7021\u201350.","journal-title":"Curr Oncol"},{"issue":"2","key":"986_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1118\/1.597927","volume":"24","author":"J Hokkanen","year":"1997","unstructured":"Hokkanen J, Heikkonen J, Holmberg P. Theoretical calculations of dose distributions for beta-ray eye applicators. Med Phys. 1997;24(2):211\u20133.","journal-title":"Med Phys"},{"key":"986_CR28","unstructured":"Botta F, Mairani A, Valente M, et al. Benchmark of FLUKA Monte Carlo code for dosimetry in nuclear medicine therapy through electron and isotopes dose point kernel calculation. JNM. 2011;52(1):1763."}],"container-title":["Radiological Physics and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12194-025-00986-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12194-025-00986-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12194-025-00986-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:04:21Z","timestamp":1781615061000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12194-025-00986-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["986"],"URL":"https:\/\/doi.org\/10.1007\/s12194-025-00986-z","relation":{},"ISSN":["1865-0333","1865-0341"],"issn-type":[{"value":"1865-0333","type":"print"},{"value":"1865-0341","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article did not contain any studies involving human or animal participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}